Kate Wen

USPTO Granted Patents = 10 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 54(Granted Patents)

Company Filing History:

Purdue Pharma, L.p., USA

patents

4. 1 out of 832,680

Other

patents

Years Active: 2009-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11608342 - PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases (2023-03-21),

2. 10513524 - PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases (2019-12-24),

3. 9993477 - Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitors (2018-06-12),

4. 9850249 - PDE9 inhibitors with imidazo triazinone backbone (2017-12-26),

5. 9643970 - Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitors (2017-05-09),

6. 9533992 - PDE9 inhibitors with imidazo triazinone backbone (2017-01-03),

7. 9434733 - PDE9 inhibitors with imidazo triazinone backbone (2016-09-06),

8. 9301953 - Therapeutic agents useful for treating pain (2016-04-05),

9. 8349842 - Therapeutic agents useful for treating pain (2013-01-08),

10. 7572812 - Therapeutic agents useful for treating pain (2009-08-11),

Title: The Innovative Journey of Inventor Kate Wen

Introduction

Kate Wen is a prominent inventor based in Shanghai, China, known for her significant contributions to the field of pharmaceutical innovations. With an impressive portfolio of ten patents, her work primarily focuses on developing novel treatments for various peripheral diseases.

Latest Patents

Among her latest patents, Kate has developed PDE9 inhibitors featuring imidazo triazinone and imidazo pyrazinone backbones. These inhibitors are specifically crafted for the treatment of benign prostate hyperplasia and sickle cell disease. Her inventions not only demonstrate her expertise but also reflect her commitment to addressing critical healthcare challenges.

Career Highlights

Throughout her distinguished career, Kate Wen has worked with notable companies such as H. Lundbeck A/S and Purdue Pharma L.P. Her role in these organizations has allowed her to lead innovative projects and contribute to cutting-edge research in the pharmacological field.

Collaborations

Kate's journey has been enriched by her collaborations with esteemed colleagues, including Niels Svenstrup and Yazhou Wang. Together, they have forged advancements in drug development, showcasing the power of teamwork in driving innovation.

Conclusion

With her remarkable achievements and dedication to medical advancements, Kate Wen continues to be a pivotal figure in the realm of pharmaceutical inventions. Her work exemplifies the essence of innovation, aiming to improve the lives of countless individuals through effective treatments.

This text is generated by artificial intelligence and may not be accurate.